Erica Ullman

2.1k total citations
13 papers, 217 citations indexed

About

Erica Ullman is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Erica Ullman has authored 13 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Immunology. Recurrent topics in Erica Ullman's work include CAR-T cell therapy research (2 papers), Peptidase Inhibition and Analysis (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Erica Ullman is often cited by papers focused on CAR-T cell therapy research (2 papers), Peptidase Inhibition and Analysis (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Erica Ullman collaborates with scholars based in United States, Sweden and Switzerland. Erica Ullman's co-authors include Susanne Rudberg, Gisela Dahlquist, Nurith Kurn, Barbara S. Vold, Salomon Minkin, Aynur Hermann, William C. Olson, Gábor Halász, Jie Dai and Douglas MacDonald and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Blood.

In The Last Decade

Erica Ullman

12 papers receiving 210 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erica Ullman United States 7 73 62 61 51 45 13 217
Cristine Dieter Brazil 9 42 0.6× 47 0.8× 23 0.4× 54 1.1× 116 2.6× 28 306
Hotaka Kamasaki Japan 9 40 0.5× 59 1.0× 29 0.5× 28 0.5× 162 3.6× 24 282
Rauf Shahbazov United States 10 51 0.7× 72 1.2× 73 1.2× 264 5.2× 67 1.5× 23 333
Tonia Kim United States 4 18 0.2× 17 0.3× 51 0.8× 32 0.6× 117 2.6× 7 256
James Henry United States 8 30 0.4× 86 1.4× 83 1.4× 275 5.4× 78 1.7× 13 343
Elisavet Ntavli United Kingdom 5 34 0.5× 59 1.0× 74 1.2× 41 0.8× 42 0.9× 6 301
L.A. Maile United Kingdom 9 63 0.9× 25 0.4× 18 0.3× 21 0.4× 84 1.9× 10 350
Min Shen China 11 33 0.5× 46 0.7× 46 0.8× 57 1.1× 92 2.0× 20 232
Stefan R. Havik Netherlands 9 16 0.2× 17 0.3× 23 0.4× 28 0.5× 69 1.5× 17 230
Aristeidis Giannakopoulos Greece 9 26 0.4× 191 3.1× 78 1.3× 13 0.3× 183 4.1× 30 296

Countries citing papers authored by Erica Ullman

Since Specialization
Citations

This map shows the geographic impact of Erica Ullman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica Ullman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica Ullman more than expected).

Fields of papers citing papers by Erica Ullman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erica Ullman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica Ullman. The network helps show where Erica Ullman may publish in the future.

Co-authorship network of co-authors of Erica Ullman

This figure shows the co-authorship network connecting the top 25 collaborators of Erica Ullman. A scholar is included among the top collaborators of Erica Ullman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erica Ullman. Erica Ullman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Jiang, Zaoli, Michael Rosconi, Bojie Zhang, et al.. (2024). A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants. Cancer Research. 84(13). 2169–2180. 3 indexed citations
2.
Olson, Kara, David J. DiLillo, Olga Sineshchekova, et al.. (2024). A CD38xCD28 Costimulatory Bispecific Antibody Demonstrates Potent Preclinical Combinatorial Activity with a BCMAxCD3 T Cell-Engager. Blood. 144(Supplement 1). 3283–3283. 1 indexed citations
3.
Lee, Ken-Wing, Yi Zhou, Matthew C. Franklin, et al.. (2024). Characterization of Linvoseltamab's BCMA Binding Epitope and Efficacy Against BCMA Mutations in Relapsed/Refractory Multiple Myeloma. Blood. 144(Supplement 1). 3265–3265. 7 indexed citations
4.
Bloch, Nicolin, Jurriaan Brouwer‐Visser, Erica Ullman, et al.. (2022). Interference in a Neutralizing Antibody Assay for Odronextamab, a CD20xCD3 Bispecific mAb, from Prior Rituximab Therapy and Possible Mitigation Strategy. The AAPS Journal. 24(4). 76–76. 2 indexed citations
5.
Nagashima, Kirsten, Kaitlyn Gayvert, Chandrashekhar K. Korgaonkar, et al.. (2022). Evaluation of Common Gamma Chain Cytokine Signaling Blockade with REGN7257, an Interleukin 2 Receptor Gamma (IL2RG) Monoclonal Antibody, on Immune Cell Populations in Monkey and Human. Blood. 140(Supplement 1). 2924–2925. 1 indexed citations
6.
Burova, Elena, Aynur Hermann, Jie Dai, et al.. (2019). Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human PD-1xLAG-3 –Knockin Mice. Molecular Cancer Therapeutics. 18(11). 2051–2062. 62 indexed citations
7.
Ullman, Erica, et al.. (2014). Altered Transcriptional Control Networks with Trans-Differentiation of Isogenic Mutant-KRas NSCLC Models. Frontiers in Oncology. 4. 344–344. 16 indexed citations
8.
Leener, Benjamin De, Erica Ullman, Samuel Kadoury, & Julien Cohen‐Adad. (2014). PropSeg: automatic spinal cord segmentation method for MR images using propagated deformable models. 5.
9.
Kurn, Nurith, et al.. (2000). Branch migration inhibition in PCR-amplified DNA: homogeneous mutation detection. Nucleic Acids Research. 28(9). e42–e42. 6 indexed citations
10.
Vold, Barbara S., et al.. (1996). DELISA: sensitive nonisotopic assay for GAD65 autoantibodies, a key risk-assessment marker for insulin-dependent diabetes mellitus. Clinical Chemistry. 42(2). 263–269. 17 indexed citations
11.
Laney, Maureen, et al.. (1996). Formation of chimeric DNA primer extension products by template switching onto an annealed downstream oligonucleotide.. Proceedings of the National Academy of Sciences. 93(7). 2969–2974. 19 indexed citations
12.
Rudberg, Susanne, Erica Ullman, & Gisela Dahlquist. (1993). Relationship between early metabolic control and the development of microalbuminuria ? a longitudinal study in children with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 36(12). 1309–1314. 81 indexed citations
13.
Dafforn, Alan, et al.. (1990). Rapid, simple, and reliable doctor's office test for antibodies to human immunodeficiency virus 1 in serum.. PubMed. 36(7). 1312–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristine Dieter Breakdown of academic impact, for papers by Hotaka Kamasaki Breakdown of academic impact, for papers by Rauf Shahbazov Breakdown of academic impact, for papers by Tonia Kim Breakdown of academic impact, for papers by James Henry Breakdown of academic impact, for papers by Elisavet Ntavli Breakdown of academic impact, for papers by L.A. Maile Breakdown of academic impact, for papers by Min Shen Breakdown of academic impact, for papers by Stefan R. Havik Breakdown of academic impact, for papers by Aristeidis Giannakopoulos
Rankless by CCL
2026